Abstract. Stress signals induce ceramide (cer) through sphingomyelinase activation, and metabolites of cer such as sphingosine (Sph) and sphingosine-1-phoshate (S-1-P) play a significant role in many biological processes. This study aimed to elucidate the association between the alteration in cell surface sialylation and ceramide-induced cell death in the human Burkitt's lymphoma cell line, HBL-8. The highly sialylated 3G3 clone was less sensitive to C6-ceramideinduced cell death. On the other hand, the hyposialylated 3D2 clone was more sensitive to C6-ceramide-induced cell death. Neuraminidase treatment or knockdown by siRNA of uridine diphosphate-N-acetylglucosamine 2-epimerase (UDP-GlcNAc2-epimerase), which is a key enzyme of sialic acid biosynthesis, enhanced the amount of cell death induced by C6-ceramide in the highly sialylated 3G3 clone. Sialic acid metabolic complementation assays using several precursors of sialic acid showed that cell surface resialylation by N-acetyl-D-mannosamine (ManNAc) inhibited C6-ceramideinduced cell death. The amount of cell death by C6-ceramide was enhanced after pretreatment with phosphatidylinositol 3-kinase (PI3K) inhibitor, LY294002 in both clones. In addition, clone 3G3 was less sensitive to Sph than the 3D2 clone. In conclusion, in human malignant lymphoma, ceramide and its metabolite-induced cell death is regulated by the amount of sialic acid on the cell surface which in turn is regulated by mRNA expression of UDP-GlcNAc2-epimerase.
Introduction
Sialic acids are important regulators of cellular and molecular interactions. They can either mask recognition sites or serve as recognition determinants (1) . Sialic acid plays an important role in tumor cell behavior by affecting cell adhesion, invasiveness, and metastasis (2-7), as well as affecting clinical outcomes (8, 9) and Fas-induced apoptosis (10) (11) (12) . Uridine diphosphate-N-acetylglucosamine 2-epimerase (UDPGlcNAc2-epimerase) is a key enzyme in sialic acid biosynthesis (13) , and is essential for development in mice (14) . Expression of UDP-GlcNAc2-epimerase mRNA was found to correlate with the sialic acid content in a human Burkitt's lymphoma cell line and to regulate the expression of sialoglycoconjugates, which affect the adhesion of Burkitt's lymphoma cells to collagen type IV and fibronectin (15) .
Sphingolipids modify the physical properties of cell membranes (16) . Ceramide, sphingosine, and Sphingosine-1-phosphate (S-1-P) are associated with cell growth arrest and are important regulatory components of stress responses and apoptosis (17) . Stress signals produce ceramide (18, 19) , and ceramide is converted to sphingosine by the activity of ceramidase and subsequently converted to sphingosine-1-phosphate by the activity of sphingosine kinase (20) at the cell surface or extracellular milieu (21) . Sphingosine induces a rapid necrotic cell death (22) .
Cell surface sialylation is reported to modulate the susceptibility to sphingomyelinase and subsequent production of ceramide in a human diffuse large B cell lymphoma cell line (23) , as well as regulate sphingolipid-induced cell death in human B cell lymphoma cell lines (24) .
In the present study we show that alteration in cell surface sialylation regulates ceramide and its metabolite-induced cell death in a human Burkitt's lymphoma cell line.
Materials and methods
Cell lines. HBL-8 is a human Burkitt's lymphoma cell line (5) . HBL-8 cells were grown at 37˚C in RPMI-1640 containing 15% fetal calf serum and in an atmosphere containing 5% CO 2 . The two clones of HBL-8 (3G3 and 3D2) show different reactivities to soybean agglutinin (SBA) and Vicia villosa agglutinin (VVA) lectins as well as different metastatic capacities in the severe combined immunodeficiency (SCID) mouse animal model (5) . These clones have a different amount of cell surface sialic acid due to differences in the mRNA expression of UDP-GlcNAc2-epimerase, which is a key enzyme in sialic acid biosynthesis (15) . Expression of the mRNA for ß-galactoside-α2,6-sialyltransferase (ST6Gal I) and Galß(1-3/1-4)GlcNAc-α2,3-sialyltransferase (ST3Gal IV) are detected in both the 3G3 and 3D2 clones (15) .
Antibodies and reagents. Biotinylated Limax flavus agglutinin (LFA) and Maackia amurensis agglutinin (MAA), which are sialic acid-specific lectins, were from EY Laboratories (San Mateo, CA, USA). Neuraminidase from Vibrio cholerae was purchased from Roche (Germany). C6-ceramide were from Sigma (USA). Sphingosine and Sphingosine-1-phosphate were from Biomol (USA). N-acetyl-D-mannosamine (ManNAc), N-acetyl-D-glucosamine, and α-D-Mannose (Man) were from Sigma. The caspase inhibitor carbobenzoxy-L-valyl-ß-methyl-L-aspart-1-fluoromethane (z-VAD-fmk) was obtained from Peptide Institute, Inc. (Japan) and was dissolved in dimethyl sulfoxide. 6 cells were incubated at 37˚C for 30 min in 200 μl of RPMI-1640 containing 15% fetal calf serum and 40 μl of 1 U/ml Vibrio cholerae neuraminidase (Boehringer-Mannheim, Germany) before incubation with biotinylated lectins (15) .
For the sialic acid metabolic complementation assay, the HBL-8 3D2 clone cells (1x10 7 cells) were incubated with 10 mM ManNAc or Man in 25 ml RPMI-1640 culture medium containing 15% FCS for 72 h at 37˚C. Then the LFA lectin reactivity was analyzed by flow cytometry as previously described.
For analysis by the Annexin-V-FLUOS Staining kit (Roche, Germany), HBL-8 cells (2x10 6 cells) were suspended in 100 μl of incubation buffer (included in the kit) with 2 μl Annexin-V-fluorescein and 2 μl propidium iodide (PI) at RT for 15 min. After centrifugation, cells were resuspended by sheath flow fluid and analyzed by FACSCalibur.
Transfection of siRNA for UDP-GlcNAc2-epimerase in the HBL-8 3G3 clone.
In order to analyze the regulatory mechanism of cell surface sialylation by mRNA expression of UDP-GlcNAc2-epimerase, siRNA transfection was performed as described previously with several modifications (25) . Cells (1x10 6 )/500 μl in 15% FCS containing RPMI-1640 medium were incubated in each well of a 24-well plate. Then 2 μl INTERFERin (Polyplus Transfection, USA) reagent was added to 100 μl serum-free medium, and 1 μl siRNA (sense, GGUUUUUAUGGGUACUUUUtt; antisense, AAAAGUAC CCAUAAAAACCtg, catalogue no. 700, Ambion K.K. Japan) (50 μM, final concentration 500 nM) and immediately vortexed for 10 min. Then the 100 μl serum-free medium containing 500 nM siRNA was added to each well (1x10 6 cells/500 μl, final concentration of siRNA was 83 nM). For control experiments, Ambion Silencer™ negative control siRNA (catalogue no. 4611) was applied. After 48-h incubation, the amount of cell surface sialylation was analyzed by MAA lectin flow cytometry.
Detection of mRNA of UDP-GlcNAc2-epimerase by RT-PCR.
Total RNA was extracted from HBL-8 cell lines using TRIsol (Invitrogen, The Netherlands) according to the manufacturer's instructions. After adding 5 μg of total RNA with 1 μl of 1000 pmol random primers (Takara Bio) and 1 μl of 10 mM dNTP mixture (Takara), reverse transcription was performed using SuperScript III Rnase H-Reverse Transcriptase (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol. Aliquots of cDNA (1 μg) were amplified using Takara Ex Taq HS polymerase in a total volume of 50 μl. For detection of UDP-GlcNAc2-epimerase mRNA, PCR was performed using UDP-GlcNAc2-epimerase (EC 5.1.3.14) specific primers (15) (forward primer: 5'-GAGATG GTTCGAGTGATGC-3', reverse primer: 5'-TAACTATTTC ACCCTTCATGCT-3'). ß-actin was also amplified using specific primers (forward primer: 5'-GACTATGACTTAGTT GCGTTA-3', reverse primer: 5'-GCCTTCATACATCTCAA GTTG-3') (15) . All primers were synthesized by Bex Co., Ltd. (Tokyo, Japan). Amplification was performed with 5 μl 10xExTaq Buffer (Takara), 4 μl dNTP mix (Takara), 0.25 μl rTaq (Takara), 38.25 μl distilled water, forward and reverse primers (1 μl each), and 1 μl template cDNA using a GeneAmp PCR System 9700 (PE Applied Biosystems). Cycling conditions for amplification of UDP-GlcNAc 2-epimerase mRNA were 30 sec at 94˚C, 60 sec at 50˚C, and 90 sec at 72˚C for 70 cycles; and for ß-actin, 30 sec at 95˚C, 30 sec at 55˚C, and 30 sec at 72˚C for 30 cycles. PCR-products were electrophoresed in a 2% agarose gel. The PCR products were visualized by staining with ethidium bromide. For analysis of growth inhibitory effects of siRNA transfection for UDP-GlcNAc2-epimerase, the number of lymphoma cells was counted by trypan-blue exclusion methods.
Quantitative real-time PCR analysis. Total RNA was extracted from HBL-8 cell lines using TRIsol (Invitrogen) according to the manufacturer's instructions. After adding 5 μg of total RNA with 1 μl of 1000 pmol random primers (Takara) and 1 μl of 10 mM dNTP mixture (Takara), reverse transcription was performed using SuperScript III Rnase H-Reverse Transcriptase (Invitrogen) according to the manufacturer's protocol. PCR was performed with the Quanti test SYBR Green PCR Master mix (Qiagen, USA) using UDP-GlcNAc2-epimerase (EC 5.1.3.14) specific primers (15) (forward primer: 5'-GAGATGGTTCGAGTGA TGC-3', reverse primer: 5'-TAACTATTTCACCCTTCAT GCT-3'). Cycling conditions for amplification of UDPGlcNAc 2-epimerase mRNA were 30 sec at 94˚C, 60 sec at 50˚C, and 90 sec at 72˚C for 60 cycles. For human glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA, amplification was performed using forward primer (5'-ATCA CTGCCACCCAGAAG-3'), reverse primer (5'-CAGTGAGC TTCCCGTTCA-3'), and cycling conditions of 15 sec at 94˚C, 15 sec at 60˚C, and 20 sec at 72˚C for 45 cycles. Real-time PCR reactions and data analysis were performed with LightCycler (Roche, Germany). The amount of mRNA was calculated based on the relative mRNA concentration (UDP-GlcNAc2-epimerase/GAPDH).
Cell growth with metabolic complementation of sialic acid by
ManNAc. In order to analyze the effects of resialylation by the sialic acid complementation assay, the HBL-8 3D2 clone cells were incubated with 30 mM ManNAc or Man for 72 h at 37˚C, and then the number of lymphoma cells was counted by trypan-blue exclusion methods.
C6-ceramide or Sph-induced cell death. HBL-8 clones were grown for 2 days and then seeded at 37˚C in 96-well microtiter plates at 5x10 4 cells/well in 100 μl phenol red and serum-free culture medium containing C6-ceramide (final concentrations: 20 μM) (Sigma) or Sph (Biomol Research Laboratories, Inc., USA) at various concentrations for various lengths of time. Next, 10 μl of WST-1 reagent was added to each well, and the plates were incubated for 1 h or 2 h at 37˚C. The plates were then shaken for 1 min at room temperature, and the absorbance at 450-655 nm or 450 nm was measured using a model 550-microplate reader (Bio-Rad, CA, USA). To evaluate the effects of cell surface desialylation, 5x10 6 cells were incubated at 37˚C for 30 min in 200 μl of RPMI-1640 containing 15% fetal calf serum and 40 μl of 1 U/ml Vibrio cholerae neuraminidase (Boehringer-Mannheim) before incubation with C6-ceramide or Sph. For analysis of the effects of resialylation by the sialic acid complementation assay, the HBL-8 3D2 clone cells were incubated with 30 mM ManNAc or Man for 72 h at 37˚C, and then the cell death induced by C6-ceramide was evaluated by WST-1 assay as previously described.
To evaluate the effects of cell surface desialylation by knockdown of UDP-GlcNAc2-epimerase using siRNA, siRNA was transfected into the HBL-8 3G3 clone cells as described above. After 72-h incubation with siRNA, the HBL-8 3G3 clone cells were incubated with C6-ceramide (final concentration: 40 μM) for 12 h and then cell viability was analyzed by WST-1 methods as described above.
Membrane permeability detected by LDH release assay. HBL-8 clones were grown for 2 days and then seeded at 37˚C in 96-well microtiter plates at 5x10 4 cells/well in 50 μl phenol-red and serum-free culture medium containing C6-ceramide (final concentration: 40 μM) (Sigma) for 1 h at RT. Then the amount of LDH release was quantified using the Cytotoxicity detection kit (Roche, Germany) with slight modifications. First, 100 μl of reaction mixture solution (included in the kit, according to the manufacturer's instruction) reagent was added to each well, and the plates were incubated for 5 min at RT. Stop solution (50 μl) was added to each well and the absorbance at 450-655 nm was measured using a model 550-microplate reader (Bio-Rad). The experiment was performed on 3G3 and 3D2 clones to compare the amount of LDH between them. To evaluate the effects of cell surface desialylation, 5x10 6 cells were incubated at 37˚C for 60 min in 200 μl of RPMI-1640 containing 15% fetal calf serum and 40 μl of 1 U/ml Vibrio cholerae neuraminidase (Boehringer-Mannheim) before incubation with C6-ceramide.
Caspase in C6-ceramide-induced cell death. Two HBL-8 clones were grown for 2 days and then seeded at 37˚C in 96-well microtiter plates at 5x10 4 cells/well in 100 μl phenolred and serum-free culture medium with or without broad caspase inhibitor, z-VAD-fmk (120 μM) (Peptide Institute, Japan) at 37˚C for 30 min. Then cells were incubated with C6-ceramide (final concentration: 20 μM) (Sigma) at 37˚C for 24 h with or without z-VAD-fmk (120 μM). Then cell viability was evaluated by WST-1 assay as described above.
Involvement of PI3K in C6-ceramide-induced cell death. Two HBL-8 clones were grown for two days and then seeded at 37˚C in 96-well microtiter plates at 5x10 4 cells/well in 100 μl phenol-red and serum-free culture medium with or without PI3K inhibitor, LY294002 (60 μM) (Calbiochem) at 37˚C for 30 min. Then cells were incubated with C6-ceramide (final concentration: 40 μM) (Sigma) at 37˚C for 3 h with or without LY294002 (60 μM). Then cell viability was evaluated by WST-1 assay as described above.
Morphology of cell death. Giemsa-stained Cytospin ® HBL-8 cell preparations were evaluated for morphological changes during ceramide-induced cell death.
Results

Cell surface sialylation on HBL-8 clones.
Flow cytometric analysis showed that the 3G3 clone of HBL-8 cells showed substantial cell surface binding of LFA lectin, but only slight binding was found on the 3D2 clone (Fig. 1a) . In the sialic acid metabolic complementation assay, cell surface resialylation was observed in the 3D2 clone by complementation of ManNAc into the culture medium, but not by complementation of GlcNAc and Man (Fig. 1b) . Transfection of siRNA for UDP-GlcNAc2-epimerase in the HBL-8 3G3 clone showed a reduction in MAA lectin reactivity (negative cont siRNA: 82.89% -siRNA for epimerase: 67.38% = ~15% reduction) compared to that for the negative control siRNA (Fig. 1c) . RT-PCR analysis showed that transfection of siRNA inhibited expression of UDP-GlcNAc2-epimerase mRNA compared to that of the negative control, and that there was no significant difference in the expression of ß-actin between the two clones (Fig. 1d) . Real-time RT-PCR analysis also revealed that the relative concentration (UDP-GlcNAc2-epimerase/GAPDH) decreased for the UDP-GlcNAc2-epimerase siRNA knock-down compared to that of the negative control siRNA transfection (Fig. 1e) . For the siRNA knockdown, the number of lymphoma cells decreased compared to the negative control experiment after 72-h incubation (Fig. 1f) . The number of 3D2 clone cells markedly increased upon incubation with ManNAc, which is effective for cell surface resialylation, but not with mannose (Man), which is not effective for cell surface resialylation (Fig. 1g) .
C6-ceramide-or Sph-induced cell death.
The highly sialylated 3G3 clone was less sensitive to C6-ceramide. On the other hand, cell death of the hyposialylated 3D2 clone was markedly induced by treatment with C6-ceramide (Fig. 2a) . The neuraminidase treatment enhanced the amount of cell death induced by C6-ceramide in the highly sialylated 3G3 clone (Fig. 2b) . Clone 3G3 was less sensitive to Sph than the 3D2 clone (Fig. 2c) . Pretreatment with neuraminidase enhanced Sph-induced cell death in the 3G3 clone (Fig. 2d) . 
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Clone 3G3 was less sensitive to S-1-P than the 3D2 clone (data not shown). The sialic acid metabolic complementation assays using several precursors of sialic acid in the 3D2 clone showed that supplementation with ManNAc (30 mM, 72 h) inhibited C6-ceramide-induced cell death compared to that with Man (Fig. 2e) . The cell viability of the 3G3 clone with siRNA knockdown of UDP-GlcNAc2-epimerase decreased with incubation with C6-ceramide (40 μM for 12 h) more so than that of the negative control siRNA transfection after 72-h incubation (Fig. 2f) .
Membrane permeability detected by LDH release assay. The amount of extracellularly released LDH was detected with the Cytotoxicity detection kit. The amount of released LDH was enhanced with neuraminidase pre-treatment in the highly sialylated 3G3 clone treated with C6-ceramide (40 μM, 60 min) (Fig. 3a) . The amount of released LDH was more for the 3D2 clone compared to the 3G3 clone when treated with C6-ceramide (40 μM, 120 min) (Fig. 3b) .
Analysis of C6-ceramide induced cell death by Annexin-V and PI staining.
The HBL-8 3G3 clone was less sensitive to C6-ceramide (40 μM, 24 h) and 3D2 was relatively more sensitive to C6-ceramide than that of the 3G3 clone. Almost all of the dead cells from C6-ceramide-induced cell death were PI-positive, necrotic cells, but not apoptotic cells (Fig. 4) . 
Involvement of caspase in C6-ceramide-induced cell death.
C6-ceramide induced cell death in both the 3G3 and 3D2 clones, and the 3G3 clone was less sensitive to C6-ceramide than the 3D2 clone (Fig. 5) . Furthermore, C6-ceramide-induced cell death was not blocked by z-VAD-fmk, and the amount of cell death was enhanced by pretreatment with z-VAD-fmk in both clones.
Involvement of PI3K on C6-ceramide-induced cell death.
The amount of C6-ceramide-induced cell death was enhanced after pretreatment with PI3K inhibitor, LY294002 in both HBL-8 clones (Fig. 6) . Morphological changes during ceramide-induced cell death. Both 3G3 and 3D2 clones incubated with C6-ceramide (40 μM, 24 h) showed cell swelling and the appearance of cytoplasmic vacuoles (Fig. 7) , and the morphological appearance indicated necrosis, not apoptosis.
Discussion
Stress signals are considered to produce ceramide through the sphingomyelin pathway, for example via sphingomyelinase (SMase) activity and following cell death (18, 19) . Ceramide is converted to sphingosine by the activity of ceramidase and is subsequently converted to sphingosine-1-phosphate by the activity of sphingosine kinase (20) at the cell surface or extracellular milieu (21) . Sphingosine induces rapid, necrotic cell death (22) . In the present study, cell surface sialylation appears to be closely associated with ceramide or sphingosineinduced cell death. As shown in Fig. 8 , cell surface sialylation Under stressful conditions, a highly sialylated cell surface protects lymphoma cells from ceramide or sph-induced cell death, whereas hyposialylation enhances the sensitivity to ceramide or sph-induced cell death. Figure 9 . A schematic representation of the regulatory mechanism of cell surface sialylation in ceramide or sph-induced membrane permeability death, including the kinase-dependent regulatory mechanisms in ceramide or sph-induced cell death.
regulates the susceptibility to ceramide and sphingolipids, and in a condition such as a marked stress response, which produces ceramide or sphingolipids, cell surface sialylation protects lymphoma cells from ceramide or sphingolipidinduced cell death. The present study showed cell death induced by C6-ceramide was regulated by cell surface sialylation and was independent of caspase activation. Ceramide-induced apoptosis has been reported to be mitochondria-mediated and caspasedependent (26) , in other studies, C2-ceramide has been reported to enhance caspase-dependent cell death in a glioma cell line (27) , or to induce caspase-independent necrosis showing cytoplasmic vacuolation (28) . In addition, necrotic cell death is found to be enhanced by treatment with z-VADfmk (29) . Therefore, cell death induced by C6-ceramide in HBL-8 clones seems to be enhanced by treatment with z-VADfmk, suggesting that blocking caspase activation enhances the amount of cell death through the necrotic pathway. Flow cytometric analysis showed that almost all of the dead cells induced by C6-ceramide were positive for PI, suggesting the enhancement of cell membrane permeability by C6-ceramide, and the LDH release assay revealed that cell surface sialylation inhibits C6-ceramide-mediated membrane permeability of 3G3 clone cells. Therefore, there is a possibility that the difference in C6-ceramide mediated membrane permeability between the HBL-8 clones is regulated by cell surface sialylation. Furthermore, cell death induced by ceramide showed cell swelling and cytoplasmic vacuoles. These morphological features are consistent with necrosis rather than apoptosis (28, 29) . Taken together, these data indicate that cell death induced by ceramide in HBL-8 clones appears to be caspase-independent necrosis and that the differences in the amount of necrosis are regulated by cell surface sialylation. Goni and Alonso, recently reported that ceramide and sphingolipids modified the physical properties of the cell membrane (16), and Montes et al reported that ceramide induced an increased efflux or permeability in cell membranes (30) . Therefore, the evidence suggests that ceramide or sphingolipids induce the enhancement of membrane permeability death through a caspase-independent pathway, and consequently necrotic cell death and cell membrane permeability induced by ceramide are regulated by cell surface sialylation.
There have been several reports on the correlation between PI3K and the sphingomyelinase pathway as a mechanism for cell survival/death decisions involving cross-talk between the pathways (31). PI3K activity is reported to be inhibited by ceramide (32) . In the present study, as shown in Fig. 9 , the PI3K inhibitor, LY294002 enhanced the amount of C6-ceramide-induced cell death in both HBL-8 clones. Therefore, the activity of PI3K appears to inhibit C6-ceramide-induced cell death.
There was a significant difference in the susceptibility of the HBL-8 clones to ceramide or Sph, and an increase of cell surface sialylation reduced susceptibility of the clone cells to ceramide or Sph-induced cell death. Neuraminidase treatment enhanced cell death induced by C6-ceramide in the highly sialylated 3G3 clone. Furthermore, the sialic acid complementation assay using ManNAc in the hyposialylated 3D2 clone showed that cell surface resialylation by ManNAc complementation inhibited cell death induced by ceramide. These data suggest that cell surface sialic acid can protect lymphoma cells from ceramide-induced cell death. A highly sialylated 3G3 clone has been found to be more metastatic than a hyposialylated 3D2 clone in the metastatic SCID mouse model of human lymphoma cell lines (5) . Lymphoma cells may be exposed to a stressful environment in the blood stream or in distant target organs upon metastasis, and various stresses induce ceramide or sphingolipid which is produced by the sphingomyelin pathway in vivo (19) . In addition, the inhibition of cell death is reported to be a crucial characteristic of metastatic cancer cells (33) . Therefore increased cell surface sialylation may reduce susceptibility of the 3G3 clone cells to ceramide or sphingolipid-induced cell death, leading to increased metastatic colonization of distant target organs. mRNA expression of UDP-GlcNAc2-epimerase is known to correlate with the sialic acid content among two clones of HBL-8, 3G3 and 3D2 (15) , and in our experiments, the knockdown of UDP-GlcNAc2-epimerase for the highly sialylated 3G3 clone decreased cell surface sialylation and also enhanced C6-ceramide-induced cell death. These data suggest that cell surface sialylation by expression of UDPGlcNAc2-epimerase is closely associated with the inhibition of ceramide-induced cell death, and that lymphoma cells may escape from stress-induced cell death through cell surface sialylation regulated by UDP-GlcNc2-epimerase, leading to an increase of metastatic colonization of distant organs.
In conclusion, cell death induced by ceramide and its metabolites in a human Burkitt's lymphoma cell line appears to be influenced by cell surface sialylation. This mechanistic model may provide a new scientific foundation in tumor cell biology of human malignant lymphoma.
